The company would not disclose its full list of pharmacy partners, and the only pharmacy name provided traces back to an entity that entered a federal plea agreement and whose Kentucky permit expired in 2021
Mounjaro, containing tirzepatide, is approved for diabetes management but is frequently prescribed off-label for chronic weight management
DOI: 10.1016/j.drudis.2025.104333, Pratt, E., Ma, X., Liu, R., et al
To support your plan: Eat protein-rich meals Stay hydrated Prioritize sleep Add light daily movement Be consistent with dosing GLP-1 treatment may support weight management when combined with lifestyle habits and provider-guided medical support
Below the 72-hour minimum
Best For: Patients who prefer a shorter-acting medication Those who didnt respond well to semaglutide-based medications People seeking moderate, steady weight loss Patients who want an FDA-approved weight loss medication with years of safety data What to Know: The daily injection schedule requires more commitment than weekly options, but some patients actually prefer this
